Vittra APS Unique Nano-Hybrid Universal Shade Composite Syringe

FGM SKU: 4000055660
Price
Regular price $2585
Regular price Sale price $2585
/
Shipping calculated at checkout.

FGM Vittra APS Unique in the 4 g syringe presentation is a sub-micrometric composite that mirrors the shade of the tooth from Bleach to D4 through a chameleon effect. Eliminating shade selection increases productivity while still delivering high esthetics, excellent shine and mechanical strength.

Key Features

  • One shade for all shades — covers Bleach to D4

  • Chameleon effect copies the colour of the dental substrate

  • Exclusive APS (Advanced Polymerization System) technology

  • High esthetics and mechanical resistance

  • BPA free; 4 g syringe for higher-volume use

Technical Specifications

  • Material: Sub-micrometric light-cure composite resin, BPA free

  • Shade: Universal — one shade covering Bleach to D4

  • Presentation: Syringe with 4 g

  • Qualities: BPA free, high esthetics and mechanical resistance, exclusive APS technology, agility and economy, one composite for all shades, chameleon effect

  • Purpose: Permanent and deciduous teeth; direct restorations on anterior and posterior teeth (classes I, II, III, IV, V and VI)

  • Technique Note: In classes I, II, V and VI, if darkening is present, cover the area with a dentin composite or opacifier before restoring incrementally with Vittra APS Unique. In classes III and IV without a back wall to support the shade, place a background layer first and finish the remaining volume incrementally.

  • Certifications: FDA Approved, CE Approved, MDR, MDSAP, ISO 13485:2016

  • Country of Manufacture: Brazil

  • Package Includes: 1 syringe with 4 g

Clinical Applications

  • Single-shade direct restorations in anterior and posterior teeth

  • Restorations in deciduous teeth

  • High-volume practices seeking to simplify composite stock

Why Choose the 4 g Syringe?
The bulk syringe format is the economical choice for practices already committed to the single-shade workflow, versus the single-dose capsules.